Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle

Abstract

mRNA is a novel class of therapeutic modality that holds great promise in vaccination, protein replacement therapy, cancer immunotherapy, immune cell engineering etc. However, optimization of mRNA molecules and efficient in vivo delivery are quite important but challenging for its broad application. Here we present an ionizable lipid nanoparticle (iLNP) based on iBL0713 lipid for in vitro and in vivo expression of desired proteins using codon-optimized mRNAs. mRNAs encoding luciferase or erythropoietin (EPO) were prepared by in vitro transcription and formulated with proposed iLNP, to form iLP171/mRNA formulations. It was revealed that both luciferase and EPO proteins were successfully expressed by human hepatocellular carcinoma cells and hepatocytes. The maximum amount of protein expression was found at 6 h post-administration. The expression efficiency of EPO with codon-optimized mRNA was significantly higher than that of unoptimized mRNA. Moreover, no toxicity or immunogenicity was observed for these mRNA formulations. Therefore, our study provides a useful and promising platform for mRNA therapeutic development.

Delivery of pOXR1 through an injectable liposomal nanoparticle enhances spinal cord injury regeneration by alleviating oxidative stress

“…Plasmids are accessible tools for modulating molecule expression, delivering plasmids using biological materials could enhance plasmid efficiency, concentration and biological stability [ 16 ]. In particular, liposome-based nanoparticles are known to be good carriers for the loading, transport and release of plasmids to their target [ 17 , 18 ]. Consistent with previous studies, a novel liposome modified with vitamin E and natural poly ε-lysine (ε-PLL) was constructed to simultaneously encapsulate the OXR1-EGFP fusion plasmid (pOXR1) [ 19 , 20 ].…”

Study the lipidoid nanoparticle mediated genome editing protein delivery using 3D intestinal tissue model

“…Previously, we reported a series of cationic lipidoids that were successfully employed to intracellularly deliver therapeutic proteins for cancer treatment [ [14] , [15] , [16] ]. The properties of proteins for delivery, such as charge intensity, molecular weight, and hydrophobicity impacted delivery efficiency [ 17 , 18 ]. In addition, different proteins for delivery required distinct lipidoids formulations.…”

Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication

“…This therapy may not cause any side effects inside our body as the mRNA's are biodegradable and transient,but efficient delivery of mRNA to the target cell is difficult when compared to other drugs. To overcome this, a nano-carrier like a lipid nano-particle delivery system is currently in use exclusively for delivering the nucleic acid drugs like mRNA and Si-RNA [ 143 , 144 ]. In a computational study, the adsorbing ability of hydroxychloroquine on different metal nanoparticles like Ag, Au, Ag, Au, and Pt were evaluated.…”